CureVac N.V. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -84.16M-110.55M-153.95M-470.99M-254.07M-279.92M173.31M
Share-based Compensation -5.02M21.66M16.98M17.11M9.37M8.28M4.40M
Deferred Taxes -1.31M-1.81M0.00M-0.12M
Gains from Investment Securities -0.06M-0.27M-7.06M-0.67M12.22M3.74M0.69M
Asset Writedowns and Impairment 26.09M6.73M2.65M37.72M
Non-cash Items 6.43M
Cash from Operations -87.55M-96.26M622.86M-838.68M-291.97M-288.23M108.84M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 4.47M7.93M12.72M17.93M24.22M25.16M20.10M
Change in Working Capital
Change in Receivables -6.61M-11.20M18.28M-19.08M9.69M-8.70M
Change in Inventory 1.04M-3.59M-9.94M-260.21M-48.82M-51.58M0.63M
Change in Account Payables 11.11M-10.61M739.58M205.13M-98.13M-32.38M-150.23M
Investing Activities
Capital Expenditures 11.11M12.37M43.31M142.11M89.81M56.29M15.30M
Cash from Investing Activities -5.04M31.19M-53.98M-146.32M-95.39M-59.39M-19.71M
Financing Activities
Cash from Financing Activities -0.13M75.25M977.48M394.63M64.45M248.43M-5.46M
Additional items
Exchange Rate Effect 0.25M0.12M-6.02M5.65M0.85M-1.24M1.07M
Change in Cash -92.72M10.18M1546.35M-590.36M-322.91M-99.20M83.66M
Free Cash Flow -98.66M-108.62M579.54M-980.78M-381.78M-344.52M93.54M
Net Cash Flow -92.72M10.18M1546.35M-590.36M-322.91M-99.20M83.66M